News

Experian Reminds Shareholders of Upcoming Dividend Choices

Experian Reminds Shareholders of Upcoming Dividend Choices

Experian Notifies Shareholders About Dividend Elections

Experian plc, a leading global data and technology company, has reminded its shareholders to make their dividend election choices regarding the first interim dividend. This important communication emphasizes the approaching deadline for submitting preferences on how to receive dividends, whether through UK sourced Income Access Share arrangements or in US dollars.

Understanding the Dividend Options

The threshold for shareholders to submit their dividend elections is set for January 10, 2025. The dividend itself was previously announced and is offered at 19.25 US cents per ordinary share. Payment is scheduled for February 7, following the cut-off date for shareholder registration, which also aligns with the election submission deadline.

Previous Elections Carry Forward

In the event that shareholders do not submit new election instructions, their existing preferences will automatically remain in effect. Specifically, those who have not opted for UK sourced dividends will default to receiving Irish sourced dividends, which may incur a withholding tax. To circumvent this tax, it is essential for shareholders to provide a valid exemption form to the Company's share registrars by the evening of the deadline.

Choosing Dividend Currency

Shareholders who wish to receive their dividends in US dollars instead of sterling must clearly indicate their choice before the specified date. The relevant converter exchange rate will be established shortly after this deadline on January 17, 2025. For shareholders dealing with uncertificated shares through CREST, it's crucial to follow the prescribed dividend election procedures, while those with certificated shares must fill out and return the designated election form available through Experian's dedicated shareholder portal or from the share registrars directly.

About Experian and Its Operations

Experian, prominently listed on the London Stock Exchange under the ticker EXPN and also a member of the FTSE 100 Index, boasts a sizable workforce of over 22,500 employees operating across 32 nations. This dynamic company excels in leveraging data, analytics, and advanced software to deliver valuable solutions to a diverse range of industries, including finance, healthcare, and automotive sectors.

Contacting Shareholder Services

Shareholders requiring further details or assistance regarding the dividend election process are encouraged to reach out to the Dividend Planning Team of the share registrars. Their dedicated team can provide the necessary information tailored to facilitate a smooth experience for all shareholders.

Frequently Asked Questions

What is the deadline for dividend election choices?

Shareholders must submit their dividend election choices by January 10, 2025.

How much is the first interim dividend being offered?

The first interim dividend is set at 19.25 US cents per ordinary share.

What happens if I do not make a new election?

If no new election is made, previous choices will automatically apply for the current dividend.

Can I receive my dividend in US dollars?

Yes, shareholders can choose to receive their dividends in US dollars, but they must indicate their preference by the deadline.

How can shareholders contact Experian for more information?

Shareholders can reach out to the Dividend Planning Team from Experian’s share registrars for any queries or assistance needed.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles